Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0H7KQ
|
|||
| Drug Name |
ABBV-8E12
|
|||
| Synonyms |
C2N-8E12
Click to Show/Hide
|
|||
| Indication | Alzheimer disease [ICD-11: 8A20; ICD-10: G30, G30.9; ICD-9: 331] | Phase 2 | [1] | |
| Progressive supranuclear palsy [ICD-11: 8A00.10; ICD-10: G23.1] | Phase 2 | [2] | ||
| Company |
AbbVie North Chicago, IL C2N Diagnostics St. Louis, MO
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03712787) An Extension Study of ABBV-8E12 in Early Alzheimer's Disease (AD). U.S. National Institutes of Health. | |||
| REF 2 | ClinicalTrials.gov (NCT02985879) A Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of ABBV-8E12 in Subjects With Progressive Supranuclear Palsy (PSP). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.